Nomad Power Solutions NMAD
NASDAQ NMAD
$3.60 +0.07 (+1.98%)
At close: Oct 22, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Accumulated Expenses (2018)

Updated

Nomad Power Solutions (NMAD) posted Accumulated Expenses of $50,000 for Q3 2018, unchanged from the prior quarter.

Analysis

Nomad Power Solutions (NMAD) Accumulated Expenses (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Nomad Power Solutions 49.18 Mn 27.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 50,000.00
Jun 30, 2018 50,000.00
API Access

Nomad Power Solutions Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NMAD&period=max&api_key=YOUR_API_KEY